• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6型和11型人乳头瘤病毒具有抗原性不同的、强烈免疫原性的、构象依赖性中和表位。

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes.

作者信息

Christensen N D, Kirnbauer R, Schiller J T, Ghim S J, Schlegel R, Jenson A B, Kreider J W

机构信息

Department of Pathology, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033.

出版信息

Virology. 1994 Nov 15;205(1):329-35. doi: 10.1006/viro.1994.1649.

DOI:10.1006/viro.1994.1649
PMID:7526536
Abstract

Antibodies reactive to HPV types 6 and 11 were tested in ELISA and HPV-11 neutralization assays to determine whether these closely related types shared cross-reactive neutralizing epitopes. A series of HPV-11 neutralizing monoclonal antibodies (N-MAbs) that targeted conformational epitopes on infectious HPV-11 and HPV-11 L1 virus-like particles (VLPs) were tested for type-specificity of reactivity using intact HPV-6 L1 VLPs. Polyclonal antisera generated against intact HPV-6 L1 VLPs were also tested for HPV-11 neutralizing capacity using the athymic mouse xenograft system. The results demonstrated that conformationally dependent neutralizing epitopes on HPV-11 were very type-specific. Three of the four HPV-11 N-MAbs were negative for binding to HPV-6 L1 VLP, and the fourth demonstrated binding to HPV-6 L1 VLPs that was several orders of magnitude weaker than its binding to HPV-11 L1 VLP. The polyclonal anti-HPV-6 L1 VLP antiserum was only partially protective against HPV-11 infectivity even at a low dilution of 1:100. In contrast, polyclonal anti-HPV-11 L1 VLP antiserum was completely protective at dilutions greater than 1:10,000.

摘要

在ELISA和HPV-11中和试验中检测了对HPV 6型和11型有反应的抗体,以确定这些密切相关的类型是否共享交叉反应性中和表位。使用完整的HPV-6 L1病毒样颗粒(VLP),对一系列靶向感染性HPV-11和HPV-11 L1病毒样颗粒上构象表位的HPV-11中和单克隆抗体(N-MAb)进行反应性的型特异性检测。还使用无胸腺小鼠异种移植系统检测了针对完整HPV-6 L1病毒样颗粒产生的多克隆抗血清的HPV-11中和能力。结果表明,HPV-11上依赖构象的中和表位具有很强的型特异性。四种HPV-11 N-MAb中的三种与HPV-6 L1 VLP结合呈阴性,第四种与HPV-6 L1 VLP 的结合比其与HPV-11 L1 VLP的结合弱几个数量级。即使在1:100的低稀释度下,多克隆抗HPV-6 L1 VLP抗血清对HPV-11感染性也只有部分保护作用。相比之下,多克隆抗HPV-11 L1 VLP抗血清在大于1:10,000的稀释度下具有完全保护作用。

相似文献

1
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes.6型和11型人乳头瘤病毒具有抗原性不同的、强烈免疫原性的、构象依赖性中和表位。
Virology. 1994 Nov 15;205(1):329-35. doi: 10.1006/viro.1994.1649.
2
HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.人乳头瘤病毒11型突变体病毒样颗粒引发可中和病毒的免疫反应,并界定了一个新的中和结构域。
Virology. 2000 Jan 20;266(2):237-45. doi: 10.1006/viro.1999.0083.
3
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.杂交乳头瘤病毒L1分子组装成病毒样颗粒,这些颗粒可重构构象表位并诱导针对不同HPV类型的中和抗体。
Virology. 2001 Dec 20;291(2):324-34. doi: 10.1006/viro.2001.1220.
4
Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.抗独特型抗体诱导针对乳头瘤病毒的中和抗体
Virology. 1995 Jul 10;210(2):292-301. doi: 10.1006/viro.1995.1346.
5
Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.通过插入交叉反应性L2表位对人乳头瘤病毒样颗粒疫苗进行修饰。
J Med Virol. 2008 May;80(5):841-6. doi: 10.1002/jmv.21124.
6
Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.人乳头瘤病毒31型L1/L2病毒样颗粒诱导的型特异性和交叉反应性抗体。
J Med Microbiol. 2007 Jul;56(Pt 7):907-913. doi: 10.1099/jmm.0.47073-0.
7
Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.人乳头瘤病毒33型主要衣壳蛋白中中和表位的特性分析
Virol J. 2006 Oct 2;3:83. doi: 10.1186/1743-422X-3-83.
8
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.针对人乳头瘤病毒6型L1病毒样颗粒的单克隆抗体,除了能识别6型特异性表位外,还能识别11型人乳头瘤病毒上的构象性和线性中和表位。
Virology. 1996 Oct 15;224(2):477-86. doi: 10.1006/viro.1996.0554.
9
[Immunogenicity study of HPV 6b virus-like particles].[人乳头瘤病毒6b型病毒样颗粒的免疫原性研究]
Zhonghua Yi Xue Za Zhi. 2002 May 10;82(9):587-9.
10
Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.接种酵母衍生的人乳头瘤病毒11型(HPV-11)L1病毒样颗粒疫苗的女性血清对HPV-11的中和作用:与竞争性放射免疫分析效价的相关性
J Infect Dis. 2001 Nov 1;184(9):1183-6. doi: 10.1086/323645. Epub 2001 Sep 27.

引用本文的文献

1
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70.一种针对人乳头瘤病毒39型、68型和70型的大肠杆菌衍生三型嵌合疫苗的特性分析
NPJ Vaccines. 2022 Oct 31;7(1):134. doi: 10.1038/s41541-022-00557-y.
2
Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.SARS-CoV-2 蛋白的单克隆抗体作为探针,评估冠状病毒的结构和抗原特性。
Viruses. 2021 Sep 22;13(10):1899. doi: 10.3390/v13101899.
3
Production and characterization of a novel HPV anti-L2 monoclonal antibody panel.
新型 HPV 抗 L2 单克隆抗体检测试剂盒的研制及鉴定。
Virology. 2018 Nov;524:106-113. doi: 10.1016/j.virol.2018.08.017. Epub 2018 Aug 28.
4
Description of a novel multiplex avidity assay for evaluating HPV antibodies.一种用于评估人乳头瘤病毒抗体的新型多重亲和力检测方法的描述。
J Immunol Methods. 2017 Aug;447:31-36. doi: 10.1016/j.jim.2017.04.004. Epub 2017 Apr 19.
5
Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.表位组学:从致癌性人乳头瘤病毒 58 型中 E6、E7 和 L1 蛋白的 IgG-表位解码
Sci Rep. 2016 Oct 6;6:34686. doi: 10.1038/srep34686.
6
Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.从烟草叶片中可扩展生产人乳头瘤病毒16型L1蛋白和病毒样颗粒
PLoS One. 2016 Aug 12;11(8):e0160995. doi: 10.1371/journal.pone.0160995. eCollection 2016.
7
A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.一项冷冻电子显微镜研究确定了完整的H16.V5表位,并揭示了由中和抗体片段结合引发的整体构象变化。
J Virol. 2015 Jan 15;89(2):1428-38. doi: 10.1128/JVI.02898-14. Epub 2014 Nov 12.
8
Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).人乳头瘤病毒(HPV)6、11、16 和 18 血清流行率与性行为和年龄有关:来自多国 HPV 男性感染研究(HIM 研究)的结果。
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):990-1002. doi: 10.1158/1055-9965.EPI-10-1160. Epub 2011 Mar 4.
9
Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid.鉴定针对 Merkel 细胞多瘤病毒衣壳的单克隆抗体。
Virology. 2010 Sep 15;405(1):20-5. doi: 10.1016/j.virol.2010.06.022. Epub 2010 Jul 3.
10
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies.包装有 L2 基因的乳头瘤病毒假病毒可诱导交叉中和抗体。
J Transl Med. 2010 Mar 24;8:28. doi: 10.1186/1479-5876-8-28.